SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Eur Respir J. 2016;48(1):104-14.

Bronchodilator response following methacholine-induced bronchoconstriction predicts acute asthma exacerbations.

, , , , , ,

제1저자 박흥우 · 교신저자 박흥우

PMID 27076579 DOI 10.1183/13993003.00182-2016 IF 23.8 알레르기내과
소속 (6)
  1. The Channing Division of Network Medicine, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Dept of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea guinea71@snu.ac.kr.
  2. Dept of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  3. Dept of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  4. The Channing Division of Network Medicine, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  5. The Channing Division of Network Medicine, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Partners Center for Personalized Medicine, Partners Health Care, Boston, MA, USA.
  6. The Channing Division of Network Medicine, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Division of Pulmonary and Critical Care Medicine, Dept of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Abstract

Methacholine bronchial provocation test provides the concentration of methacholine causing a 20% decrease in forced expiratory volume in 1 s (FEV1) from baseline (PC20). The dose-response slope (DRS), and other continuous indices of responsiveness (CIR; the percentage decline from the post-diluent baseline FEV1 after the last dose of methacholine), and per cent recovery index (PRI; the percentage increase from the maximally reduced FEV1 after bronchodilator inhalation) are alternative measures. The clinical relevance of these indices in predicting acute asthma exacerbations has not been fully evaluated.In two prospective cohorts of childhood and elderly asthmatics, baseline PC20, DRS, CIR and PRI were measured and evaluated as predictors of acute asthma exacerbations.We found that PRI was significantly related to the presence of asthma exacerbations during the first year of follow-up in both cohorts of childhood (p=0.025) and elderly asthmatics (p=0.003). In addition, PRI showed a significant association with the total number of steroid bursts during 4.3 years of follow-up in the cohort of childhood asthmatics (p=0.04).We demonstrated that PRI, an index of reversibility following methacholine-induced bronchoconstriction, was a good clinical predictor of acute exacerbations of asthma in both childhood and elderly asthmatics.

Copyright ©ERS 2016.

그 밖의 정보
출판 형태
Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
저널
The European respiratory journal · eISSN 1399-3003
전자 출판
2016-04-13
MeSH
Administration, Inhalation · Aged · Asthma / drug therapy · Boston · Bronchial Provocation Tests · Bronchoconstriction / drug effects · Bronchoconstrictor Agents / pharmacology · Bronchodilator Agents / therapeutic use · Child · Disease Progression* · Female · Forced Expiratory Volume / drug effects · Humans · Logistic Models · Male · Methacholine Chloride / pharmacology · Prospective Studies · Republic of Korea
Substances
Bronchoconstrictor Agents · Bronchodilator Agents · Methacholine Chloride
연구비
NHLBI NIH HHS N01HR16052 · NHLBI NIH HHS N01HR16045 · NHLBI NIH HHS U01 HL075232 · NHLBI NIH HHS U01 HL075408 · NHLBI NIH HHS U01 HL075419 · NCRR NIH HHS M01 RR000051 · NHLBI NIH HHS U01 HL075415 · NHLBI NIH HHS N01HR16048 · NHLBI NIH HHS N01HR16051 · NHLBI NIH HHS N01HR16049 · NHLBI NIH HHS N01HR16050 · NCRR NIH HHS M01 RR002719 · NHLBI NIH HHS N01HR16046 · NHLBI NIH HHS U01 HL075417 · NHLBI NIH HHS U01 HL075416 · NHLBI NIH HHS U01 HL075409 · NHLBI NIH HHS N01HR16047 · NHLBI NIH HHS N01HR16044 · NHLBI NIH HHS U01 HL075407 · NINR NIH HHS R01 NR013391 · NHLBI NIH HHS U01 HL075420 · NHLBI NIH HHS U01 HL065899